🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey J. Raizer

Northwestern University

ORCID: 0009-0003-8469-2509

Also affiliated with Amyotrophic Lateral Sclerosis Therapy Development Institute, Northwestern University, Takeda (United States), Northwestern Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer”.

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03555-z
N/A
1.9DataRank · unranked
82 citations

Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Morris D. Groves +12 more

Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3874
N/A
0.706DataRank · unranked
110 citations

Lijie Zhai, Kristen L. Lauing, April Bell, Jiahui Xu, Masha Kocherginsky +20 more

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2664
N/A
0.689DataRank · unranked
98 citations

Juan Manuel Sepúlveda-Sánchez, Timothy F. Cloughesy, Miguel Gil‐Gil, Vinay K. Puduvalli, Jeffrey J. Raizer +15 more

A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics

Neuro-Oncology(2022)10.1093/neuonc/noac195
N/A
0.663DataRank · unranked
82 citations

Michael J. Avram, Andrew B. Lassman, Nancy U. Lin, Eudocia Q. Lee, Sean Grimm +13 more

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae202
N/A
0.345DataRank · unranked
9 citations

Adam L. Cohen, Midori Eckenstein, Randy L. Jensen, Lindsay Burt, Karen L. Salzman +18 more

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

Neuro-Oncology(2020)10.1093/neuonc/noaa062
N/A
0DataRank · unranked
46 citations

Jing Wu, Ying Yuan, Terri S. Armstrong, Elizabeth Vera, Jimin Wu +18 more

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168
N/A
0DataRank · unranked
116 citations

Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown +18 more